eLifeSystems BiologyPeer-reviewed journal article
Exploration of the Metabolomic Mechanisms of Postmenopausal Hypertension Induced by Low Estrogen State
Abstract
BackgroundEstrogen significantly impacts womens health, and postmenopausal hypertension is a common issue characterized by blood pressure fluctuations. Current control strategies for this condition are limited in efficacy, necessitating further research into the underlying mechanisms. Although metabolomics has been applied to study various diseases, its use in understanding postmenopausal hypertension is scarce. MethodsAn ovariectomized rat model was used to simulate postmenopausal conditions. Estrogen levels, blood pressure, and aortic tissue metabolomics were analyzed. Animal models were divided into Sham, OVX, and OVX+E groups. Serum estrogen levels, blood pressure measurements, and aortic tissue metabolomics analyses were performed using radioimmunoassay, UHPLC-Q-TOF, and bioinformatics techniques. ResultsThe study successfully established a correlation between low estrogen levels and postmenopausal hypertension in rats. Notable differences in blood pressure parameters and aortic tissue metabolites were observed across the experimental groups. Specifically, metabolites that were differentially expressed, particularly L-alpha-aminobutyric acid (L-AABA), showed potential as a biomarker for postmenopausal hypertension, potentially exerting a protective function through macrophage activation and vascular remodeling. Enrichment analysis revealed alterations in sugar metabolism pathways, such as the Warburg effect and glycolysis, indicating their involvement in postmenopausal hypertension. ConclusionThis research provides insights into the metabolic changes associated with postmenopausal hypertension, highlighting the role of AABA and sugar metabolism reprogramming in aortic tissue. The findings suggest a potential link between low estrogen levels, macrophage function, and vascular remodeling in the pathogenesis of postmenopausal hypertension. Further investigations are needed to validate these findings and explore their clinical implications for postmenopausal women.
- Citations
- 1
- FWCI
- 0.59
- Field percentile
- top 42%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- New insights into the metabolomic signatures of spontaneously hypertensive rats
Celia Rodríguez‐Pérez, Alejandra Vázquez-Aguilar, … María Dolores Mesa·PLoS ONEPeer-reviewed·Apr 3, 2026
- Gut microbial metabolic flux disorder in hypertension
Wenkai Lai, Yuchen Zhang, … Fenglong Yang·bioRxiv·Oct 9, 2024
- Estrogen-Deficiency Degrades Left Ventricular Diastolic Function and Energy Metabolism in Hypertensive Female Mice
Aijun Zhang, Shumin Li, … Anisha A. Gupte·bioRxiv·Jun 10, 2026
- Unraveling the Mechanistic Links Between Blood Pressure Regulation and Calcium-Magnesium Homeostasis: Insights into Hypertension, Hyperparathyroidism, and Mineral Disorders
Pritha Dutta, Anita T. Layton·PLoS ONEPeer-reviewed·Feb 4, 2026
- A physiology-based mathematical model of the renin-angiotensin system, bone remodeling, and calcium homeostasis: Effects of estrogen and renin-angiotensin system inhibitors
Melissa M. Stadt, Victoria A. Ralph, Anita T. Layton·PLoS Computational BiologyPeer-reviewed·Sep 22, 2026
- Pericytes mediate neurovascular remodeling in chronic arterial hypertension
Lorena Morton, Alejandra P. Garza, … Ildikò Rita Dunay·bioRxiv·May 13, 2024